| Country / Region | Valuation technique | Year of data collection | Publication |
|---|---|---|---|
| Slovenia | TTO + DCE | 2019-2020 | Prevolnik Rupel V, Ogorevc, M, IMPACT HTA HRQoL Group. et al.; EQ-5D-Y Value Set for Slovenia; PharmacoEconomics 39, 463–471 (2021) |
| Japan | TTO + DCE | 2020 | Shiroiwa T, Ikeda S, Noto S, Fukuda T, Stolk E; Valuation Survey of EQ-5D-Y Based on the International Common Protocol: Development of a Value Set in Japan; Medical Decision Making 1–10 |
| Spain | TTO + DCE | 2020 | Ramos-Goni J, Oppe M, Estevez-Carillo A, Rivero-Arias O; Accounting for Unobservable Preference Heterogeneity and Evaluating Alternative Anchoring Approaches to Estimate Country-Specific EQ-5D-Y Value Sets: A Case Study Using Spanish Preference Data; Value in Health, 2021 |